No Data
No Data
Truist Financial Maintains Caribou Biosciences(CRBU.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Olema Pharmaceuticals (OLMA) and Privia Health Group (PRVA)
Truist Financial Remains a Buy on Caribou Biosciences (CRBU)
Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19
Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Caribou Biosciences Analyst Ratings